Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy.

PURPOSE To evaluate the long term tumor control and toxicity of skull base tumors treated with pencil beam scanning proton therapy (PT). MATERIALS AND METHODS PT was delivered to 151 (68%) and 71 (32%) chordoma and chondrosarcoma (ChSa) patients, respectively. Mean age of patients was 40.8±18.4years and the male to female ratio was 0.53. The postoperative tumor was abutting the brainstem or optic apparatus in 71 (32.0%) patients. The postoperative mean gross tumor volume (GTV) was 35.7±29.1cm(3). The delivered mean PT dose was 72.5±2.2GyRBE. RESULTS After a mean follow-up of 50 (range, 4-176) months, 35 local (15.8%) failures were observed between 10.9 and 85.4months. The estimated 7-year LC rate for chordoma (70.9%; CI95% 61.5-81.8) was significantly lower compared to the LC rate for ChSa patients (93.6%; 95%CI 87.8-99.9; P=0.014). The estimated 7-year distant metastasis-free- and overall survival rate was 91.6% (95%CI 91.6-98.6) and 81.7% (95%CI 74.7-89.5), respectively. On multivariate analysis, optic apparatus and/or brainstem compression, histology and GTV were independent prognostic factors for LC and OS. The 7-year high grade toxicity-free survival was 87.2 (95%CI 82.4-92.3). CONCLUSIONS PBS PT is an effective treatment for skull base tumors with acceptable late toxicity. Optic apparatus and/or brainstem compression, histology and GTV allow independent prediction of the risk of local failure and death in skull base tumor patients.

[1]  M. Yasuda,et al.  Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients , 2012, Neurosurgical Review.

[2]  C. Haie-meder,et al.  Radiation Therapy for Chordoma and Chondrosarcoma of the Skull Base and the Cervical Spine , 2003, Strahlentherapie und Onkologie.

[3]  G. Nielsen,et al.  Base of Skull Chordomas in Children and Adolescents: A Clinicopathologic Study of 73 Cases , 2006, The American journal of surgical pathology.

[4]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[5]  Oliver Jäkel,et al.  Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: First long‐term results , 2014, Cancer.

[6]  A. Niemierko,et al.  Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. , 1999, International journal of radiation oncology, biology, physics.

[7]  J. Tonn,et al.  Male sex as a risk factor for the clinical course of skull base chordomas. , 2014, Journal of neurosurgery.

[8]  M. Fagundes,et al.  Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse. , 1995, International journal of radiation oncology, biology, physics.

[9]  A. Trofimov,et al.  Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. , 2009, International journal of radiation oncology, biology, physics.

[10]  J. Munzenrider,et al.  Proton therapy for tumors of the skull base , 1999, Strahlentherapie und Onkologie.

[11]  I. Yang,et al.  A systematic review of intracranial chondrosarcoma and survival , 2009, Journal of Clinical Neuroscience.

[12]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer , 2014, Physics in medicine and biology.

[13]  E. Hug.  Review of skull base chordomas: prognostic factors and long-term results of proton-beam radiotherapy. , 2001, Neurosurgical focus.

[14]  A. Rosenberg,et al.  Proton radiation therapy for chordomas and chondrosarcomas of the skull base. , 1999, Journal of neurosurgery.

[15]  C. Haie-meder,et al.  Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protonthérapie D'Orsay experience. , 2001, International journal of radiation oncology, biology, physics.

[16]  O. Al-Mefty,et al.  Chordomas of the skull base: follow-up review and prognostic factors. , 2001, Neurosurgical focus.

[17]  N. Tamaki,et al.  Surgical approaches and strategies for skull base chordomas. , 2001, Neurosurgical focus.

[18]  D. Dahlin,et al.  Chordomas and cartilaginous tumors at the skull base , 1973, Cancer.

[19]  E. Pedroni,et al.  Spot scanning for 250 MeV protons. , 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[20]  J. Schlom,et al.  Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine , 2013, Oncotarget.

[21]  Alessandra Bolsi,et al.  Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. , 2009, International journal of radiation oncology, biology, physics.

[22]  B. Scheithauer,et al.  Chordoma and chondroid neoplasms of the spheno‐occiput: An immunohistochemical study of 41 cases with prognostic and nosologic implications , 1993, Cancer.

[23]  M. Wick,et al.  Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. , 1993, Archives of pathology & laboratory medicine.

[24]  J. Healey,et al.  Chordoma: a critical review of diagnosis and treatment. , 1989, The Orthopedic clinics of North America.

[25]  Y. Fujii,et al.  Cranial base chordoma – long term outcome and review of the literature , 2008, Acta Neurochirurgica.

[26]  G. Nielsen,et al.  A novel target for treatment of chordoma: signal transducers and activators of transcription 3 , 2009, Molecular Cancer Therapeutics.

[27]  R. Stupp,et al.  Phase II study of imatinib in advanced chordoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Munzenrider,et al.  Base of skull and cervical spine chordomas in children treated by high-dose irradiation. , 1995, International journal of radiation oncology, biology, physics.

[29]  M. McDermott,et al.  Skull Base Chondrosarcoma Originating from the Petroclival Junction , 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[30]  J. O'Connell,et al.  Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases , 1994, Cancer.

[31]  M. McDonald,et al.  Clinical Investigation : Central Nervous System Tumor Proton Therapy for Reirradiation of Progressive or Recurrent Chordoma , 2013 .

[32]  J. Habrand,et al.  Radiotherapeutic Factors in the Management of Cervical-basal Chordomas and Chondrosarcomas , 2004, Neurosurgery.

[33]  M. Moore,et al.  Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma. , 2015, International journal of radiation oncology, biology, physics.

[34]  B. Scheithauer,et al.  Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. , 1993, Journal of neurosurgery.

[35]  A. Parsa,et al.  Skull base chondrosarcoma: evidence-based treatment paradigms. , 2013, Neurosurgery clinics of North America.

[36]  K. Herfarth,et al.  High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: First report of long‐term results , 2014, Cancer.

[37]  A. Lomax,et al.  Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute. , 2016, Neuro-oncology.

[38]  G. Noël,et al.  Irradiation par association de photons et de protons des chordomes et des chondrosarcomes de la base du crâne et du rachis cervical , 2002 .

[39]  K. Schaller,et al.  Incidence and relative survival of chordomas , 2013, Cancer.